We are pleased to introduce Dr Andrew Dimond, Senior Research Associate in Biochemistry at the University of Oxford, where he investigates how chromatin and transcription factors are regulated during mitosis. His research integrates molecular biology, imaging, ‘omics’, and structural approaches to understand genome regulation through mitosis and its coupling to cell identity.
Andrew completed his PhD with Prof Peter Fraser at the Babraham Institute, University of Cambridge, where he helped pioneer the Promoter Capture Hi-C method and explored the links between polycomb repressive complexes, 3D genome organisation, and pluripotency. He later joined Prof Amanda Fisher’s group at the MRC London Institute of Medical Sciences (Imperial College London), where his postdoctoral work employed bioluminescent reporters to study epigenetic regulation in vitro and in vivo, including drug screening and the impact of environmental challenges. In 2020, he was awarded a Kay Kendall Leukaemia Fund Junior Research Fellowship to study the role of the tumour suppressor Ikaros in mitosis, through which he characterised the cancer-implicated mitotic kinase PBK as a negative regulator of mitotic bookmarking. In 2024 he relocated with the Fisher group to the University of Oxford where he continues to investigate genome regulation during cell division, harnessing degron systems, nascent transcriptomics, advanced flow cytometry and optical tweezer technologies.